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ABSTRACT
Background: Fatty liver is the leading cause of chronic liver diseases and increases the risk of cardiovascular disease.
Besides alcohol consumption, energy-containing nonalcoholic beverages may contribute to liver fat accumulation.
Objective: We aimed to study the consumption of alcoholic and nonalcoholic beverages and their mutual replacement
in relation to hepatic triglyceride content (HTGC) in middle-aged men and women.
Methods: In this cross-sectional analysis, HTGC was assessed by proton magnetic resonance spectroscopy. Habitual
consumption of alcoholic and nonalcoholic beverages was assessed using a validated food-frequency questionnaire.
All beverages were converted to standard servings and to percentage of total energy intake (En%). We performed
linear regression to examine the association of alcoholic and nonalcoholic beverages with HTGC, adjusted for age,
sex, smoking, education, ethnicity, physical activity, total energy intake, and total body fat. We studied replacement
of alcoholic beverages with nonalcoholic beverages per 1 serving/d and per 5 En%/d.
Results: After exclusion of individuals with missing values, 1966 participants (47% men) were analyzed, with a
mean ± SD age of 55 ± 6 y, BMI of 26 ± 4 kg/m2, and HTGC of 5.7% ± 7.9%. Each extra alcoholic serving per day was
associated with more liver fat (1.09 times; 95% CI: 1.05, 1.12). Replacing 5 En% of alcoholic beverages with milk was
associated with less liver fat (0.89 times; 95% CI: 0.81, 0.98), whereas replacement with 5 En% of sugar-sweetened
beverages was associated with liver fat to an extent similar to alcoholic beverages (1.00 times; 95% CI: 0.91, 1.09).
Conclusion: In a population-based cohort, consumption of each extra daily alcoholic beverage was associated with
more liver fat. In isocaloric replacement of alcoholic beverages, milk was associated with less liver fat, whereas sugar-
sweetened beverages were equally associated with liver fat. This suggests that intake of alcohol and sugars may
contribute to liver fat accumulation. This trial was registered at clinicaltrials.gov as NCT03410316. J Nutr 2019;149:649–
658.
Keywords: alcohol consumption, liver fat, substitution, alcoholic beverages, nonalcoholic beverages
Introduction
Nonalcoholic fatty liver disease (NAFLD) is often defined
as a hepatic TG content (HTGC) of >5.56% not due to
excessive alcohol consumption (1). NAFLD covers a broad
clinical spectrum, ranging from the most common feature,
hepatic steatosis, to nonalcoholic steatohepatitis (NASH) and
liver cirrhosis (2), and increases the risk of end-stage liver
disease and liver-related and all-cause mortality (3–6). Although
the incidence of NAFLD is underreported and varies widely (7),
the prevalence has risen considerably over the last 2 decades (8)
to 14–34% of the general population in Europe (9, 10), Asia
(11), and the United States (7, 11). The prevalence of NAFLD
in obesity might even be as high as 90% (12), possibly due to
excessive calorie intake (13). It is the leading cause of chronic
liver diseases worldwide (14) and is also strongly associated
with the metabolic syndrome (15) and cardiovascular diseases
(16).
Excessive alcohol consumption (17) is a well-established
risk factor for both hepatic steatosis (liver fattening) and
liver disease. Current guidelines to prevent or reduce liver
Copyright C© American Society for Nutrition 2019. All rights reserved.
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fat accumulation therefore recommend that heavy alcohol
consumption should be discouraged (18). However, there is
much controversy over whether moderate alcohol consumption
should also be discouraged, because there are studies indicating
that light to moderate alcohol consumption might be protective
in relation to fatty liver and (extra)hepatic complications (18–
23), whereas in a Mendelian randomization study it has been
suggested there is no beneficial effect of moderate alcohol
consumption on the severity of NAFLD (24). Moreover, it
has been shown that liquid food leads to less satiety and
more postprandial hunger (25). Alcohol in particular is very
inefficient in activating the satiety mechanism and consuming
alcohol during meals might lead to higher food consumption
(26).
In addition, sugar-sweetened beverages (SSBs), but not diet
sodas, have been associated with fatty liver (27). This suggests
that energy-containing drinks in general, or specifically dietary
sugars, may increase liver fat as well (28, 29). As the relative
contributions of different types of nonalcoholic and alcoholic
beverage consumption to liver fat accumulation remain unclear,
we aimed to directly compare the associations of consumption
of alcoholic beverages and nonalcoholic energy-containing
and non–energy-containing beverages with HTGC in a large
sample of the general population. Insight into these associations
may contribute to lifestyle guidelines, especially with regard
to beverages, for both primary and secondary prevention
aims.
Methods
Study design and study population
The Netherlands Epidemiology of Obesity (NEO) study is a population-
based cohort study in 6671 individuals aged 45–65 y, with an
oversampling of persons with a BMI (in kg/m2) of ≥27. Men and
women aged between 45 and 65 y with a self-reported BMI of ≥27
living in the greater area of Leiden (in the west of the Netherlands) were
eligible to participate in the NEO study. In addition, all inhabitants aged
between 45 and 65 y from 1 municipality (Leiderdorp) were invited
irrespective of their BMI, allowing for a reference distribution of BMI.
Detailed information about the study design and data collection has
been described elsewhere (30).
The present study is a cross-sectional analysis of the baseline
measurements of the participants with a measurement of HTGC. For
our analyses we excluded participants with an implausibly high or low
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total energy intake (<600 kcal or >5000 kcal) and missing data on
beverage consumption or potential confounding factors.
The study was approved by the medical ethics committee of the
Leiden University Medical Center and all participants gave written
informed consent.
Beverage consumption
Habitual consumption of beverages of all participants was estimated
using a semiquantitative FFQ, which was originally designed to study
dietary fat intake (31, 32). Consumption of alcoholic and nonalcoholic
beverages was assessed in absolute frequency (times per day, week,
and month). Participants were asked about consumption of different
alcoholic beverages (beer, wine, liquor, and mixed drinks such as
cocktails). For each alcoholic beverage we used a standard serving
based on the Dutch Food Composition Database (NEVO-2011): 200
g for beer, 110 g for wine, 50 g for liquor, and 258 g for mixed
long drinks, so that each consumption contained 10 g of alcohol.
Nonalcoholic beverages were also converted to standard servings: 200 g
for nonalcoholic beers, 125 g for coffee and tea, 150 g for milk, and 150
g for SSBs (NEVO-2011). Nonalcoholic beverages were divided into
energy-containing (nonalcoholic beers, milk, and SSBs) or non-energy-
containing (tea and coffee without milk) beverages. No information
on water consumption or diet sodas was collected using the FFQ.
After the conversion to standard servings, all nonalcoholic beverages
were also summed up into 1 variable. The same was done for all
alcoholic beverages. Total alcoholic beverage consumption was divided
into subcategories: 0–0.5 g alcohol/d (including abstainers), 0.5–5 g/d,
5–15 g/d for women and 5–30 g/d for men, and lastly >15 g/d for
women and >30 g/d for men.
We assessed the reproducibility of the habitual consumption of
different beverages in a random subgroup of 100 participants who com-
pleted the FFQ for a second time ∼3 mo after the baseline measurement.
The individual measurement intraclass correlation coefficients of the
different beverages were 0.63 for SSBs, 0.81 for milk, 0.82 for coffee,
0.91 for tea, 0.79 for beer, 0.82 for wine, 0.67 for mixed drinks, and
0.89 for liquor, which can be considered good to excellent (33).
Proton magnetic resonance spectroscopy of liver fat
content
Proton magnetic resonance spectroscopy (1H-MRS) of the liver was
performed on a 1.5 Tesla whole-body MR scanner (Philips Medical
Systems) and spectra were obtained as described previously (34).
1H-MRS data were fitted using Java-based magnetic resonance user
interface software (jMRUI version 2.2) (35). HTGC relative to water
was calculated as follows: (signal amplitude of TG)/(signal amplitude
of water) × 100.
Data collection of covariates
In the baseline questionnaire, participants reported smoking behavior
in 3 categories: current, former, or never smoking (reference group).
Ethnicity was reported by self-identification in 8 categories which
we grouped into white (reference group) and other. Highest level
of education was reported in 10 categories according to the Dutch
education system and grouped into high (including higher vocational
school, university, and postgraduate education) and low education
(reference group). Physical activity during leisure time was reported
using the Short Questionnaire to Assess Health-Enhancing Physical
Activity and was expressed in metabolic equivalent of task–hours per
week (36). Data collection on other covariates has been described
previously (30).
Statistical analyses
In the NEO study there is an oversampling of persons with a BMI
of ≥27. To correctly represent associations in the general population
(37), adjustments for this oversampling were made. This was done
by weighting individuals towards the BMI distribution of participants
from the Leiderdorp municipality (38), whose BMI distribution was
similar to the BMI distribution of the general Dutch population (39)
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(Supplemental Table 1, Supplemental Figure 1). All results were based
on weighted analyses. Consequently, the results apply to a population-
based study without oversampling of individuals with a BMI ≥27. As a
result of the weighting, only percentages and proportions can be given
instead of numbers of participants. Baseline characteristics are displayed
in percentages or means ± SDs for the total population, and stratified
by sex and categories of alcohol consumption.
We performed linear regression analyses to examine the association
between alcohol consumption and liver fat. We performed 3 different
models and also stratified each model by sex, owing to the known
differences in both alcohol consumption and liver fat content between
men and women. Because of the skewed distribution of HTGC, we
used the natural logarithm of this variable in the analyses. For easier
interpretation of these results, we back transformed the regression
coefficients towards a ratio [using exp(β)] with a 95% CI. Such a
ratio, for example 1.2, can be interpreted as 1.2 times HTGC for each
extra serving per day, which would reflect an increase in HTGC from,
for example, 5% to 6%. We first performed linear regression analysis
to examine the association of alcohol consumption as a categorical
variable [0–0.5 g/d (reference), ≥0.5–5 g/d, ≥5–15 g/d for women
and ≥5–30 g/d for men, and ≥15 g/d for women and ≥30 g/d for
men] with HTGC. We tested for a linear trend (P = 0.01) and
also added a quadratic term (P = 0.49) to the model to check for
nonlinearity.
Then, we studied alcohol consumption as a continuous outcome
in 3 different ways. Firstly, we studied the association between 1
serving of alcohol (total alcohol, beer, wine, mixed drinks, and liquor)
and 1 serving of nonalcoholic beverages (SSBs, milk, coffee, tea, and
nonalcoholic beer) per day and liver fat content. This was done in both
a crude model and a multivariable linear regression model, which was
adjusted for age, sex, smoking, education, ethnicity, physical activity,
and total energy intake. Models studying separate alcoholic beverages
were also adjusted for all other alcoholic beverages, and models on
nonalcoholic beverages were also adjusted for all other nonalcoholic
beverages.
Secondly, we studied the effect of substituting 1 serving of an
alcoholic beverage with 1 serving of a nonalcoholic beverage. In these
substitution models we included a sum variable of all beverages, in
addition to each beverage separately, except for the beverage to be
substituted, in this case alcoholic beverages. Instead of total energy
intake, these substitution models were adjusted for caloric intake from
food only, to adjust for possible confounding when substituting different
beverages. Accordingly, the regression coefficients can be interpreted as
the relative change in HTGC if 1 serving/d of an alcoholic beverage was
substituted by 1 serving/d of a nonalcoholic beverage.
Thirdly, in addition to the substitution analyses based on servings,
we also performed an isocaloric substitution model replacing alcoholic
beverages with energy-containing nonalcoholic beverages. This model
was adjusted for both caloric intake from beverages and caloric intake
from food. In these analyses 5% of total energy intake (En%) from
alcoholic beverages is replaced with 5 En% from energy-containing
nonalcoholic beverages (SSBs, milk, and nonalcoholic beer) in relation
to HTGC, to examine to what extent the caloric content contributes to
liver fat content. To study whether the associations are specific for liver
fat, we also adjusted all 3 models for total body fat.
To examine to what extent consumption of alcoholic beverages was
associated with liver fat content in participants without a fatty liver, we
stratified the analyses by the arbitrary cutoff of 5.56% which indicates
a fatty liver. Next, we stratified by the rs738409 single nucleotide
polymorphism in the patatin-like phospholipase domain-containing
protein 3 (PNPLA3) gene that is associated with diffuse fat deposition in
the liver and may promote NASH, fibrosis, and cirrhosis throughout the
liver (40), to investigate whether the associations differ between carriers
and noncarriers of the single nucleotide polymorphism.
As a means of undertaking sensitivity analyses, we repeated the
substitution analysis based on servings after taking into account the
milk and sugar potentially added to coffee and tea. In the analyses
with categories of alcohol consumption, we repeated the analyses
after excluding alcohol abstainers (0 g/d) from the reference group.
In addition, we performed the models after exclusion of participants
with type 2 diabetes or cardiovascular disease, because they might
have changed their drinking habits after being diagnosed, or might
potentially react differently to sugars.
All the aforementioned analyses were predefined, and analyses not
prespecified are considered exploratory. We performed all analyses using
Stata statistical software (Statacorp) version 14.
Results
In total, 6671 participants were included in the NEO study
between September, 2008 and October, 2012, of whom 2580
underwent a liver fat measurement by 1H-MRS. However, the
limited time slot that was available per participant did not
allow time for a repeat examination when technical failures
were present (n = 497), leaving 2083 participants with a
successful liver fat measurement. After exclusion of participants
with extreme energy intake (n = 18), missing dietary data
(n = 26), missing data on potential confounding factors (n = 1
for smoking, n = 16 for education, n = 2 for ethnicity, n = 44
for physical activity in leisure time, n = 3 for total body fat, and
n = 6 for visceral adipose tissue), and 1 participant for whom
the log transformation of the liver fat could not be calculated,
1,966 participants were included in the analyses. Baseline
characteristics of these participants are presented in Table 1.
Participants with higher alcohol consumption were more often
smokers and had on average a higher education. HTGC and the
prevalence of a fatty liver were also higher in the categories with
higher alcohol consumption. Whereas men on average have a
higher coffee and beer consumption, women have a higher tea
consumption.
Table 2 displays the association between different categories
of alcohol consumption and liver fat content. Despite a linear
trend (P-trend = 0.01), light and moderate consumption were
not significantly associated with liver fat (Table 2). Compared
with no alcohol consumption (0–0.5 g/d), high alcohol
consumption (>15 g/d for women and >30 g/d for men) was
associated with more liver fat, for total alcohol consumption
(1.28 times; 95% CI: 1.06, 1.55), beer consumption (1.39 times;
95% CI: 1.08, 1.80), and wine consumption (1.28 times; 95%
CI: 1.04, 1.58) (Table 2). Results were similar when excluding
alcohol abstainers (0 g/d) from the reference group (data not
shown).
Table 3 shows the associations between consumption of
different alcoholic beverages as continuous variables and liver
fat content. Each extra alcoholic serving was associated with
more liver fat (1.09 times; 95% CI: 1.06; 1.13). When
also adjusted for total body fat to examine whether the
associations were specific for liver fat, associations attenuated
for liquor and mixed drinks, although total alcoholic beverages
remained associated with more liver fat (1.09 times; 95% CI:
1.05, 1.12).
The associations of nonalcoholic beverages are shown
in Table 4. In the total population, each extra serving of
nonalcoholic beverages was associated with less liver fat (0.97
times; 95% CI: 0.95, 0.99). Consumption of coffee (0.96
times for each extra serving; 95% CI: 0.93, 0.99), tea (0.97
times; 95% CI: 0.94, 1.00), and milk (0.95 times; 95% CI:
0.89, 1.00) were also associated with less liver fat. Results
did not differ after exclusion of participants with type 2
diabetes or cardiovascular disease or when taking the milk
and sugar added to coffee and tea into account (data not
shown).
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TABLE 2 Relative change in HTGC and 95% CIs for different categories of alcohol consumption in participants of the Netherlands









≥30 g/d men P-trend
Alcohol (total)
Multivariable-adjusted2 relative change (95% CI) 1 (ref) 1.05 (0.87, 1.25) 1.07 (0.90, 1.28) 1.28 (1.06, 1.55) 0.01
Proportion of population, % 13.7 22.2 41.0 23.1
Beer3
Multivariable-adjusted relative change (95% CI) 1 (ref) 0.94 (0.83, 1.08) 1.10 (0.93, 1.29) 1.39 (1.08, 1.80) 0.03
% 48.1 27.5 18.5 6.0
Wine3
Multivariable-adjusted relative change (95% CI) 1 (ref) 1.01 (0.88, 1.16) 1.02 (0.89, 1.18) 1.28 (1.04, 1.58) 0.16
% 23.3 32.7 34.8 9.3
1HTGC, hepatic TG content.
2Adjusted for age, sex, smoking, education, ethnicity, physical activity in leisure time, total energy intake, and total body fat. Results are based on analyses weighted towards the
BMI distribution of the general population (n = 1,966), derived from β coefficients with 95% CIs from linear regression analyses and expressed as a relative change compared
with the reference category. Such a ratio, for example 1.2, can be interpreted as 1.2 times HTGC for each extra serving per day, which would reflect an increase in HTGC from,
for example, 5% to 6%.
3Also adjusted for other alcoholic beverages. Servings equal 200 g for beer and 110 g for wine.
Table 5 shows that substituting 1 alcoholic serving with 1
nonalcoholic serving was associated with less liver fat (0.90
times; 95% CI: 0.86, 0.94) in the total population after
adjustment for potential confounding factors and total body
fat. Of the different nonalcoholic beverages, replacement with
milk (0.88 times; 95% CI: 0.82, 0.95), tea (0.89 times; 95%
CI: 0.85, 0.94), and coffee (0.88 times; 95% CI: 0.84, 0.92)
were all associated with less liver fat. Results were similar when
taking the milk and sugar added to coffee and tea into account
(data not shown).
Isocaloric substitution of 5 En% from alcoholic beverages
with 5 En% from nonalcoholic beverages (Table 6) showed
that substitution of alcohol with milk was associated with less
HTGC (0.89 times; 95% CI: 0.81, 0.98) in the total population.
Replacing 5 En% from alcohol with 5 En% from SSBs was
associated with liver fat equally strongly as was alcohol (1.00
times; 95% CI: 0.91, 1.09).
After stratifying the analyses by the cutoff of fatty liver
(HTGC >5.56%), associations between alcohol consumption
and liver fat were similar in both groups (Supplemental Table
TABLE 3 Relative change in HTGC and 95% CIs per 1 serving/d higher consumption of alcoholic
beverages in participants of the Netherlands Epidemiology of Obesity study, men and women
between 45 and 65 y of age with direct assessment of HTGC by proton magnetic resonance
spectroscopy1
Crude Multivariable Multivariable + TBF
Total alcohol
Total 1.15 (1.11, 1.19) 1.09 (1.06, 1.13) 1.09 (1.05, 1.12)
Men 1.11 (1.07, 1.15) 1.11 (1.07, 1.15) 1.09 (1.05, 1.13)
Women 1.05 (0.97, 1.14) 1.09 (1.00, 1.18) 1.10 (1.02, 1.19)
Beer2
Total 1.14 (1.09, 1.19) 1.07 (1.02, 1.11) 1.08 (1.03, 1.13)
Men 1.08 (1.04, 1.13) 1.08 (1.04, 1.13) 1.09 (1.04, 1.15)
Women 0.95 (0.84, 1.07) 1.02 (0.89, 1.17) 1.06 (0.96, 1.17)
Wine2
Total 1.13 (1.06, 1.20) 1.13 (1.06, 1.21) 1.11 (1.05, 1.18)
Men 1.13 (1.06, 1.21) 1.13 (1.06, 1.21) 1.08 (1.02, 1.15)
Women 1.12 (1.02, 1.24) 1.13 (1.02, 1.26) 1.15 (1.04, 1.28)
Liquor2
Total 1.64 (1.45, 1.86) 1.22 (1.08, 1.38) 1.06 (0.93, 1.21)
Men 1.33 (1.17, 1.50) 1.24 (1.10, 1.40) 1.10 (0.97, 1.26)
Women 1.28 (0.66, 2.48) 0.95 (0.52, 1.73) 0.62 (0.37, 1.04)
Mixed drinks2
Total 1.56 (1.34, 1.83) 1.18 (1.00, 1.40) 0.97 (0.83, 1.15)
Men 1.26 (1.09, 1.47) 1.18 (1.00, 1.40) 0.98 (0.83, 1.16)
Women 1.74 (0.95, 3.20) 1.53 (0.86, 2.71) 1.12 (0.63, 1.97)
1Multivariable analyses adjusted for age, sex, smoking, education, ethnicity, physical activity in leisure time, and total energy intake.
Results are based on analyses weighted towards the BMI distribution of the general population (n = 1,966), derived from β coefficients
with 95% CIs from linear regression analyses and expressed as a relative change. Such a ratio, for example 1.2, can be interpreted
as 1.2 times HTGC for each extra serving per day, which would reflect an increase in HTGC from, for example, 5% to 6%. HTGC,
hepatic TG content; TBF, total body fat.
2Also adjusted for other alcoholic beverages. Servings equal 200 g for beer, 110 g for wine, 50 g for liquor, and 258 g for mixed drinks.
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TABLE 4 Relative change in HTGC and 95% CIs per 1 serving/d higher consumption of
nonalcoholic beverages in participants of the Netherlands Epidemiology of Obesity study, men and
women between 45 and 65 y of age with direct assessment of HTGC by proton magnetic resonance
spectroscopy1
Crude Multivariable Multivariable + TBF
Total nonalcoholic beverages
Total 0.98 (0.95, 1.00) 0.97 (0.94, 0.99) 0.97 (0.95, 0.99)
Men 0.98 (0.95, 1.01) 0.99 (0.95, 1.02) 0.98 (0.95, 1.01)
Women 0.95 (0.91, 0.98) 0.94 (0.91, 0.97) 0.95 (0.92, 0.98)
SSBs2
Total 1.07 (1.01, 1.14) 1.05 (0.99, 1.11) 1.03 (0.98, 1.08)
Men 1.04 (0.97, 1.12) 1.07 (0.99, 1.15) 1.02 (0.96, 1.09)
Women 1.05 (0.96, 1.14) 1.02 (0.93, 1.11) 1.03 (0.95, 1.11)
Milk2
Total 1.00 (0.94, 1.07) 0.94 (0.88, 1.00) 0.95 (0.89, 1.00)
Men 0.92 (0.86, 1.00) 0.91 (0.84, 0.99) 0.92 (0.86, 0.99)
Women 1.02 (0.91, 1.13) 0.96 (0.87, 1.07) 0.97 (0.89, 1.06)
Coffee (without sugar or milk)2
Total 1.01 (0.98, 1.04) 0.96 (0.93, 0.99) 0.96 (0.93, 0.99)
Men 1.00 (0.96, 1.04) 0.99 (0.95, 1.03) 0.99 (0.95, 1.02)
Women 0.95 (0.91, 0.99) 0.92 (0.88, 0.96) 0.92 (0.88, 0.96)
Tea (without sugar or milk)2
Total 0.92 (0.89, 0.95) 0.96 (0.92, 0.99) 0.97 (0.94, 1.00)
Men 0.96 (0.92, 1.02) 0.98 (0.93, 1.03) 1.00 (0.94, 1.05)
Women 0.95 (0.92, 0.99) 0.94 (0.90, 0.98) 0.95 (0.91, 0.99)
Nonalcoholic beer2
Total 1.35 (0.99, 1.84) 1.13 (0.88, 1.45) 1.09 (0.86, 1.38)
Men 1.22 (0.90, 1.65) 1.18 (0.89, 1.57) 1.17 (0.90, 1.52)
Women 0.82 (0.40, 1.70) 0.88 (0.49, 1.59) 0.73 (0.49, 1.10)
1Multivariable analyses adjusted for age, sex, smoking, education, ethnicity, physical activity in leisure time, and total energy intake.
Results are based on analyses weighted towards the BMI distribution of the general population (n = 1,966), and derived from β
coefficients with 95% CIs from linear regression analyses and expressed as a relative change. Such a ratio, for example 1.2, can be
interpreted as 1.2 times HTGC for each extra serving per day, which would reflect an increase in HTGC from, for example, 5% to 6%.
HTGC, hepatic TG content; SSB, sugar-sweetened beverage; TBF, total body fat.
2Also adjusted for all other nonalcoholic beverages. Servings equal 150 g for SSBs, 150 g for milk, 125 g for tea and coffee, and 200
g for nonalcoholic beer.
2). Regarding the PNPLA3 polymorphism, the association
between each alcoholic beverage and HTGC was similar in
both groups (1.14 times for each extra alcoholic serving; 95%
CI: 1.07, 1.21 for GC and GG carriers; and 1.09 times; 95%
CI: 1.04, 1.15 for CC carriers).
Discussion
In this population-based cohort of 1,966 middle-aged men and
women with directly assessed liver fat content, consumption
of each extra alcoholic serving per day was associated with
more liver fat, with larger increases in liver fat with excessive
alcohol consumption. Replacing 1 alcoholic beverage with
1 nonalcoholic beverage was associated with less liver fat.
Whereas isocaloric replacement of alcohol with milk was
associated with less liver fat, isocaloric replacement with SSBs
was equally associated with liver fat.
This study was conducted within a large cohort study, in
which HTGC was directly assessed by 1H-MRS. We used
substitution analysis to directly compare different types of
beverages and their association with liver fat to each other.
The comparative nature of our study can contribute to
translation to recommendations in clinical practice, as we
have shown that consumption of both alcohol and SSBs is
associated with more liver fat, whereas milk, tea, and coffee
are associated with less liver fat. More importantly, replacing
alcohol with SSBs is therefore equally associated with liver
fat, and replacing it with milk, tea, or coffee is associated
with less liver fat. This can be translated into clear advice for
patients diagnosed with fatty liver and who are advised to stop
consuming alcohol. Lastly, extensive phenotype measurements
have been performed, allowing adjustment for many potential
confounding factors. However, an inherent limitation of the
observational cross-sectional design is that we cannot exclude
residual confounding by lifestyle factors.
Due to the cross-sectional design, another limitation of this
substitution analysis is that it is modelled on a group level
rather than on an individual level. All participants completed
a semiquantitative FFQ, based on which we estimated the
habitual beverage consumption. Although alcohol consumption
might have been misreported, intraclass correlations of the
beverages showed good to excellent reproducibility. Moreover,
by adjusting our analyses for total energy intake we partly
corrected for potential misreporting. A limitation of the FFQ
is that it did not take drinking habits into account, so
we cannot make any statements on the potential role of
drinking patterns. Also no information on diet sodas or
water was available, so no statements on these beverages
can be made. Nevertheless, this will not have influenced the
isocaloric substitution models, because only energy-containing
beverages were taken into account in this analysis. Results
from these isocaloric substitution models suggest that it is not
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TABLE 5 Relative change in HTGC and 95% CIs per 1 serving/d of alcoholic beverage substitution
by nonalcoholic beverage in participants of the Netherlands Epidemiology of Obesity study, men and
women between 45 and 65 y of age with direct assessment of HTGC by proton magnetic resonance
spectroscopy1
Crude Multivariable Multivariable + TBF
Nonalcoholic beverages (total)
Total 0.85 (0.81, 0.88) 0.89 (0.85, 0.93) 0.90 (0.86, 0.94)
Men 0.89 (0.85, 0.93) 0.90 (0.86, 0.95) 0.91 (0.87, 0.96)
Women 0.91 (0.83, 0.99) 0.87 (0.79, 0.95) 0.86 (0.80, 0.94)
Tea (without sugar or milk)2
Total 0.81 (0.78, 0.85) 0.87 (0.83, 0.92) 0.89 (0.85, 0.94)
Men 0.88 (0.82, 0.94) 0.90 (0.84, 0.96) 0.92 (0.86, 0.99)
Women 0.88 (0.79, 0.97) 0.86 (0.78, 0.94) 0.86 (0.79, 0.94)
Coffee (without sugar or milk)2
Total 0.85 (0.81, 0.89) 0.88 (0.84, 0.92) 0.88 (0.84, 0.92)
Men 0.89 (0.84, 0.94) 0.90 (0.85, 0.95) 0.91 (0.86, 0.96)
Women 0.88 (0.79, 0.97) 0.84 (0.76, 0.92) 0.83 (0.77, 0.91)
Milk2
Total 0.86 (0.80, 0.92) 0.87 (0.81, 0.93) 0.88 (0.83, 0.94)
Men 0.83 (0.77, 0.91) 0.84 (0.77, 0.91) 0.86 (0.80, 0.92)
Women 0.94 (0.82, 1.09) 0.90 (0.78, 1.03) 0.89 (0.79, 1.00)
SSBs2
Total 0.93 (0.87, 1.00) 0.98 (0.92, 1.04) 0.96 (0.91, 1.02)
Men 0.96 (0.89, 1.03) 1.00 (0.92, 1.08) 0.96 (0.90, 1.03)
Women 0.99 (0.88, 1.11) 0.95 (0.84, 1.06) 0.94 (0.85, 1.04)
1Multivariable analyses adjusted for age, sex, smoking, education, ethnicity, physical activity in leisure time, total energy intake of food,
a sum variable of all beverages, and all beverages except for alcohol and itself. Results are based on analyses weighted towards the
BMI distribution of the general population (n = 1,966), and derived from β coefficients with 95% CIs from linear regression analyses
and expressed as a relative change. Such a ratio, for example 1.2, can be interpreted as 1.2 times HTGC for each extra serving per day,
which would reflect an increase in HTGC from, for example, 5% to 6%. HTGC, hepatic TG content; SSB, sugar-sweetened beverage;
TBF, total body fat.
2Servings equal 125 g for tea and coffee, 150 g for milk, and 150 g for SSBs.
energy per se, but possibly sugars that contribute to liver fat
accumulation.
Alcohol is mainly metabolized in the liver (41) and can
induce fatty liver by increasing fatty acid synthesis in the liver.
Together with the impaired oxidation of these compounds
caused by an increased accumulation of NAD(H), alcohol
consumption may lead to increased TG synthesis, which is
the main form of fat stored in the liver (42). Although many
studies have investigated the association between light to
moderate alcohol consumption and liver fat, results have been
inconsistent and inconclusive and the exact mechanism remains
unidentified. A prospective randomized study concluded that
TABLE 6 Relative change in HTGC and 95% CIs per 5 En% of alcoholic beverage substitution by
nonalcoholic beverages in participants of the Netherlands Epidemiology of Obesity study, men and
women between 45 and 65 y of age with direct assessment of HTGC by proton magnetic resonance
spectroscopy1
Crude Multivariable Multivariable + TBF
Nonalcoholic beverages (total)
Total 0.91 (0.83, 0.98) 0.94 (0.87, 1.02) 0.94 (0.87, 1.01)
Men 0.90 (0.81, 1.00) 0.90 (0.81, 1.01) 0.88 (0.81, 0.97)
Women 0.99 (0.86, 1.14) 0.96 (0.84, 1.10) 0.96 (0.85, 1.09)
Milk
Total 0.86 (0.77, 0.97) 0.88 (0.79, 0.98) 0.89 (0.81, 0.98)
Men 0.82 (0.71, 0.95) 0.80 (0.69, 0.92) 0.82 (0.72, 0.93)
Women 0.98 (0.82, 1.17) 0.94 (0.79, 1.13) 0.94 (0.81, 1.10)
SSBs
Total 0.95 (0.85, 1.06) 1.01 (0.91, 1.12) 1.00 (0.91, 1.09)
Men 1.00 (0.86, 1.17) 1.04 (0.89, 1.22) 0.97 (0.85, 1.10)
Women 1.01 (0.87, 1.19) 0.98 (0.85, 1.14) 0.99 (0.86, 1.13)
1Multivariable analyses adjusted for age, sex, smoking, education, ethnicity, physical activity in leisure time, total energy intake from
beverages, total energy intake from food, and all beverages except for alcohol and itself. Results are based on analyses weighted
towards the BMI distribution of the general population (n = 1,966), and derived from β coefficients with 95% CIs from linear regression
analyses and expressed as a relative change. Such a ratio, for example 1.2, can be interpreted as 1.2 times HTGC for each extra serving
per day, which would reflect an increase in HTGC from, for example, 5% to 6%. En%, percent(age) of total energy intake; HTGC,
hepatic TG content; SSB, sugar-sweetened beverage; TBF, total body fat.
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moderate red wine consumption for 3 mo increased HTGC
in subjects without steatosis at baseline (43), whereas red
wine consumption for 4 wk in another randomized controlled
trial did not significantly increase liver fat compared with
de-alcoholized red wine (44). In addition, Ekstedt et al. (45)
concluded from their long-term follow-up study that moderate
alcohol consumption was associated with fibrosis progression in
patients with NAFLD and that they should be advised to refrain
from heavy episodic drinking. Modest wine consumption has
been associated with reduced prevalence of suspected (NA)FLD
in other studies (19, 21, 46, 47). In another study, light to
moderate alcohol consumption had a potentially protective
effect against insulin resistance in severely obese patients, but
not on the severity of activity and stage of liver disease (48).
Although in a recent review an association between moderate
alcohol consumption and decreased NASH and fibrosis was
shown, it was also observed that heavy episodic drinking
may accelerate fibrosis progression (49). Most of the studies
on alcohol consumption, however, including ours, did not
take drinking habits into account, only the habitual total
amount of alcohol consumed. However, even though certain
drinking patterns such as drinking outside mealtimes and
drinking multiple different alcoholic beverages lead to an
increased risk of developing alcohol-related liver damage (50),
it seems to be the cumulative consumption that is most strongly
associated with the progression of alcoholic fatty liver disease
(42). Although current literature is in disagreement about the
role of moderate alcohol consumption, none of these studies
performed substitution analysis to take into account that a
person does not simply stop drinking alcohol but may replace
the alcoholic beverages with other drinks. Moreover, results
from a recent Mendelian randomization suggest that there is
no beneficial effect of moderate alcohol consumption on the
severity of NAFLD (24). In our study, light and moderate
alcohol consumption were not associated with less liver fat,
which is in line with these findings.
In addition, isocaloric replacement of alcohol with milk was
associated with less liver fat in our study. This indicates that it
is not caloric intake per se that leads to liver fat accumulation.
The exact mechanism behind the seemingly negative association
between dairy and liver fat remains unknown, although it is
in agreement with current literature. Established biomarkers
of dietary dairy fat intake have been associated with higher
hepatic and systemic insulin sensitivity, lower fasting glucose
concentrations, and less liver fat (51). Moreover, higher low-fat
fermented dairy product consumption has also been associated
with a decreased risk of developing type 2 diabetes in a
prospective study (52).
Importantly, isocaloric replacement of alcohol with SSB
consumption was equally associated with liver fat. Taken
together with our results on substitution with milk, this suggests
a role for sugars in liver fat accumulation. Our results are in
line with recent findings from the Framingham Heart Study that
showed a significant dose–response relation between SSBs and
fatty liver disease, but not for diet soda intake (27). However,
replacement of SSBs with other beverages was not investigated
in this study.
Multiple underlying mechanisms have been proposed
through which SSBs might contribute to the development of
diabetes and cardiometabolic diseases not only via overall
weight gain, but also independently through the metabolic
effects of constituent sugars (53). It has also been suggested that
liquid foods lead to less satiety and more postprandial hunger
(25). Consumption of SSBs has been shown to induce peaks
in blood glucose and insulin concentrations, contributing to a
high glycemic state, which is in turn associated with insulin
resistance, diabetes, and coronary artery disease (53, 54). In
the Netherlands, soft drinks are one of the main sources of
fructose (55), which is mostly metabolized to lipids in the
liver and might therefore lead to an increase in hepatic de
novo lipogenesis (56, 57). In a recent trial, moderate fructose
consumption for 12 wk increased liver fat despite only a small
increase in weight and waist circumference (58). Moreover,
chronic fructose consumption has been shown to decrease
resting energy expenditure in a 10-wk trial (59). Our results
support the current literature and suggest that both alcoholic
beverages and SSBs may contribute to liver fat accumulation.
However, in clinical practice, although patients with NAFLD
are often advised not to consume alcoholic beverages (18), there
are no clear guidelines about what they should replace these
beverages with.
In conclusion, consumption of alcoholic beverages was
associated with a higher liver fat content in a population-
based cohort. Replacing a serving of alcoholic beverages with
nonalcoholic beverages was associated with less liver fat.
Importantly, in isocaloric replacement of alcoholic beverages,
SSBs were equally associated with liver fat as were alcoholic
beverages, suggesting that both alcohol and sugars may
contribute to liver fat accumulation. Although intervention
studies should confirm to what extent HTGC can actually be
changed by altering drinking habits, it is advised to specify
with what beverages alcoholic beverages should be replaced
in clinical practice, such as non-energy-containing beverages or
milk, but not SSBs.
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